Neuroimmune Modulation for Rheumatoid Arthritis: How It Works
You might be wondering how just one-minute of daily vagus nerve stimulation with the SetPoint System can help manage rheumatoid arthritis (RA). The answer to that question starts with something your body was already designed to do.
The body maintains a natural balance of immune activity, an internal set point that determines how much inflammation is the right amount. The vagus nerve, which is one of the longest nerves in your body plays a key role in managing this set point. In people with RA, unfortunately, this process is dysfunctional causing uncontrolled inflammation. The SetPoint System is designed to help restore this function through neuroimmune modulation by electrically stimulating the vagus nerve.
Your Body Has a Natural Immune Set Point
The immune system is powerful, but it is not supposed to run at full intensity all the time. Under normal conditions, your body maintains a careful balance: enough immune activity to fight infections and heal injuries, but not so much that it starts attacking healthy tissue.
You can think of this balance as a set point for immune function. When that set point is calibrated correctly, inflammation rises when your body needs to respond to a threat and then subsides once the threat is handled. It is a dynamic system, constantly adjusting.
The vagus nerve plays a central role in maintaining this balance. The vagus nerve runs from the brainstem through the neck and into the chest and abdomen, connecting to major organs including the spleen. Through this network, it acts as a direct communication line, sensing and controlling the immune system.
What Happens When That Balance Is Lost
In rheumatoid arthritis, the immune system is stuck in an overactive state. The natural feedback loop that should dial down inflammation when it is no longer needed stops working effectively. The vagus nerve is at the center of this breakdown. Vagus nerve dysfunction shows up before the clinical symptoms of RA appear, and research has shown that people who have had a procedure that disconnects the vagus nerve are more likely to develop RA. In other words, when the vagus nerve isn’t doing its job, the body loses one of its main ways of keeping inflammation in check.
Without that signal working the way it should, the body keeps producing inflammatory proteins, even when there is no real threat to respond to. The result is chronic inflammation that targets the joints, causing hallmark symptoms of RA such as pain, swelling, stiffness, and progressive damage. What’s happening underneath is a shift in the body’s natural inflammatory balance. Healthy tissue is being treated as if it were a threat, and the signal to stand down is not getting through.
Stimulating the Vagus Nerve for RA: The Pathway That Resets the Balance
Your body already has a built-in mechanism for calming inflammation. It runs directly through the vagus nerve, and scientists call it the inflammatory reflex.
Here’s the short version of how the SetPoint System works by using neuroimmune modulation for RA: a signal is sent down the vagus nerve and ultimately reaches immune cells in your spleen. Those cells receive the message and help restore themselves to reduce their production of the inflammatory proteins that are driving the disease. These cells travel in the blood to the specific joints and reduce the inflammation. It’s the body’s own way of telling the immune system to calm down.
This is not an artificial process, induced by a chemical. It’s a natural biological pathway that already exists in your body. In people with RA, this pathway is not activating effectively on its own. The signal to restore balance isn’t getting through with enough strength or frequency to bring inflammation back to where it should be. That’s where the SetPoint System comes in.
Restoring Balance
SetPoint Therapy works by stimulating the vagus nerve. It is designed to restore the body’s natural regulation of the immune system. Electrical signals delivered to the vagus nerve can help restore the immune cells to dial back the overproduction of inflammatory signals, without interfering with the body’s natural ability to fight infections.
Think of it this way: rather than shutting off the alarm system entirely, the SetPoint System helps recalibrate it, so it stops going off when there is no real fire.
For more on how this compares to other RA treatments, see 7 Ways SetPoint is a Different Therapy for RA.
Speak with a Patient Activator
How the SetPoint System Activates the Vagus Nerve Pathway
The SetPoint System is a small, implanted device, about the size of a multivitamin, that electrically stimulates the vagus nerve, activating the body’s natural anti-inflammatory pathways. Once a day, the device delivers one minute of stimulation that is designed to restore the body’s immune balance and help reduce the production of inflammatory markers.
In other words, the SetPoint System sends a signal through the same nerve, along the same pathway, that your body already uses to regulate inflammation. One minute of daily SetPoint Therapy stimulation was clinically proven to improve symptoms of RA.
You might wonder how just one minute a day can make a meaningful difference. The answer lies in how the vagus nerve pathway was designed through evolution. When the correct vagus nerve fibers are stimulated, the body’s own anti-inflammatory pathways amplify it, sending instructions that help restore immune cells to shift toward a less inflammatory state. Research suggests the effects of a single minute of stimulation can last 24 to 48 hours. More stimulation isn’t more effective. The pathway responds best with a precise, well-timed signal rather than constant input.
Because the underlying dysfunction in the anti-inflammatory pathway doesn’t go away, that daily signal matters. One focused minute each day works with the body’s own biology, giving the pathway the consistent activation it needs to keep doing its job.
What the Clinical Evidence Shows
The SetPoint System was evaluated in the RESET-RA trial, a 242-patient, randomized, double-blind, sham-controlled study that led to its FDA approval in July 2025. The study demonstrated that vagus nerve stimulation produced significantly greater improvement than a sham device.
Because SetPoint Therapy works by helping to restore the body’s natural anti-inflammatory pathway rather than suppressing the immune system, the way patients respond over time can look different from what they may have experienced with biologics or JAK inhibitors. RA develops over months or years of uncontrolled inflammation before symptoms appear, so it’s not surprising that activating the body’s own regulatory pathways takes time to restore immune balance.
That timeline can vary from patient to patient. People who have lived with RA for many years and cycled through multiple therapies may need six to nine months to see meaningful improvement, as the body works to recalibrate after prolonged dysfunction. Others, particularly those who turn to SetPoint after their first biologic or TNF inhibitor, have seen robust responses as early as three months. By 12 months, about half of all patients in the RESET-RA study had achieved clinically reduced their disease activity and 75% were managing their RA with SetPoint Therapy without the addition of a biologic or JAK inhibitor.
In July 2025, the SetPoint System became the first and only FDA-approved neuroimmune modulation device for the treatment of RA, a milestone that reflects both the strength of the clinical evidence and the significance of this entirely new approach to treating autoimmune disease.
What Patients Experience
Now that the SetPoint System is FDA approved, patients who participated in the RESET-RA trial can speak directly to what this therapy feels like in practice. Many of them have had their devices for several years at this point, and continue to see improvement in their RA symptoms.
The level of effectiveness and time to experience results varies from patient to patient. In the clinical trial, significant improvement in tender and swollen joints and disease activity was seen by three months after starting stimulation but continued to improve through 12 months. For some patients, the changes started showing up in daily life even sooner.
Lynn, who participated in the RESET-RA clinical trial, described being caught off guard by how fast she felt RA symptom relief: “I anticipated maybe a slow roll of improvement. It was incredibly fast. Remarkably fast. I could not believe how fast I improved.”
Patty, another study participant, described how the change showed up in her daily life: “After the device was activated, within a month, I started noticing differences. I wasn’t as tired. I think the biggest thing was I started doing things again.”
In the study, device-related side effects, those deemed to be associated directly with the therapy, were infrequent and typically mild or temporary, with vocal hoarseness most frequently reported. Serious adverse events that were related to the device or therapy were uncommon, occurring in fewer than two percent of patients, and occurred within 3 months of device placement. Importantly, there were no long-term serious adverse events related to the device or therapy, and no serious infection, cancers, or major cardiovascular issues related with the device or procedure that occurred during the 12-month trial. Researchers concluded that SetPoint Therapy produced durable clinical benefits with a favorable safety profile for patients with moderate to severe RA who do not respond to, or cannot tolerate, advanced RA therapies like biologics or JAK inhibitors.
I anticipated maybe a slow roll of improvement. It was incredibly fast. Remarkably fast. I could not believe how fast I improved.
- Lynn M., North Carolina
Individual results may vary. Patient stories shared with permission.
Is Neuroimmune Modulation for Rheumatoid Arthritis Right for You?
SetPoint Therapy is for adults with moderately to severely active RA who have tried one or more biologics (e.g. Humira, Enbrel, Cimzia, Remicade, Rituxan, Actemra, or Orencia) or JAK inhibitors (e.g. Xeljanz, Rinvoq, or Olumiant) and didn’t get adequate results, lost their response over time, or couldn’t tolerate the side effects. If your current treatment isn’t giving you relief, or you haven’t been able to tolerate it, SetPoint Therapy may be worth discussing with your rheumatologist.
You can complete a short form to find out if it might be a good fit for you. If you’re a potential candidate, you’ll be connected with a Patient Activator from our team who can help answer your questions and walk you through next steps.
You may also want to bring up SetPoint Therapy at your next visit directly with your rheumatologist. They can help you evaluate whether the SetPoint System might be appropriate based on your treatment history and current disease activity.